MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced it will open a new Customer Experience Centre in Düsseldorf, Germany to serve customers across the Europe, Middle East and Africa (EMEA) region and support the company’s long-term regional growth strategy. The new Customer Experience Centre is scheduled to open in summer 2026 and will feature a state-of-the-art […]

SAN JOSE, Calif. – Complete Genomics, a leading innovator in genomic sequencing, announced at the NextGen Omics & Spatial Biology Conference that it has partnered with BioTuring, developer of advanced bioinformatics algorithms and software that enables rapid OMICS analysis, to offer researchers access to SpatialX, a powerful deep-learning tool for unified multi-technology spatial data analysis compatible with STOmics chemistries designed to […]

Christian Uhrich, Investment Director at M Ventures, joins Vizgen Board of Directors; Chad Brown joins the company as Chief Commercial Officer CAMBRIDGE, Mass. — Vizgen, Inc., the life sciences company revolutionizing spatial genomics research and driving innovation in spatial multi-omics, today announced two key appointments aimed at advancing the company’s future strategy and execution. Christian Uhrich, […]

Investment from Audax Strategic Capital aims to help extend growth runway and accelerate M&A. NEW YORK & PITTSBURGH — Audax Strategic Capital (“ASC” or “Audax”), a provider of customized, mid-hold equity solutions, announced today an investment in TCP Analytical, a portfolio company of Riverarch Equity Partners (“Riverarch”) and an established manufacturer and distributor of specialty […]

SAN JOSE, Calif. – Complete Genomics, a leading innovator in genomic sequencing, announced at the NextGen Omics & Spatial Biology Conference that it has entered a commercial partnership with Human Cell Atlas (HCA) to offer its STOmics spatial transcriptomics products to HCA members. Human Cell Atlas (HCA), an international collaborative research consortium, is mapping all cell types in the […]

Innovative technology supports testing of accuracy and reliability in Autolus Therapeutics’ recently approved CAR T therapy AUCATZYL® SANTA CLARA, Calif. —  Agilent Technologies Inc. (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics’ FDA approval for AUCATZYL® , a recently approved CAR T therapy. Agilent’s advanced cell analysis instrumentation, specifically the xCELLigence Real-Time Cell Analysis (RTCA) technology, […]

Amerigo Scientific released its ultra-sensitive CLIA kits developed to detect multiple low-abundance analytes in various samples. NEW YORK, NY, UNITED STATES — Amerigo Scientific is a distributor focused on providing critical products and services to biomedical and life science communities. Recently, the company released its ultra-sensitive chemiluminescence immunoassay (CLIA) kits developed to detect multiple low abundance analytes in various samples, […]

The SAGC joins Parse’s network to meet rising demand for high-quality single cell solutions in Australia SEATTLE — Parse Biosciences, the leader in scalable and accessible single cell sequencing, is pleased to welcome the South Australian Genomics Centre (SAGC) as the newest member of its Certified Service Provider (CSP) Program. As a certified provider, the SAGC expands […]

Facility in Gliwice, Poland to boost biopharma manufacturers’ efficiency and speed to market of therapies RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services in the life sciences and advanced technology industries, announces that Ger Brophy, PhD, head of Avantor’s Scientific Advisory Board, will present highlights of the recently completed […]

Norwood, Mass. – Patricia Industries’ subsidiary Advanced Instruments, a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, today announced the execution of a definitive agreement to acquire Nova Biomedical, a manufacturer of innovative analytical instruments and consumables that are vital in guiding the treatment of patients and the development of biotechnology therapeutics. Following the […]